GCKR and GCK polymorphisms are associated with increased risk of end-stage kidney disease in Chinese patients with type 2 diabetes: The Hong Kong Diabetes Register (1995-2019)
Wang, K; Shi, M; Yang, AM; Fan, BQ; Tam, CHT; Lau, E; Luk, AOY; Kong, APS; Ma, RCW; Chan, JCN; Chow, E
Chan, JCN; Chow, E (通讯作者)，Chinese Univ Hong Kong, Prince Wales Hosp, Dept Med & Therapeut, Hong Kong, Peoples R China.;Chan, JCN; Chow, E (通讯作者)，Chinese Univ Hong Kong, Prince Wales Hosp, Li Ka Shing Inst Hlth Sci, Hong Kong, Peoples R China.;Chow, E (通讯作者)，Chinese Univ Hong Kong, Prince Wales Hosp, Phase Clin Trial Ctr 1, Hong Kong, Peoples R China.;Chan, JCN (通讯作者)，Chinese Univ Hong Kong, Prince Wales Hosp, Dept Med & Therapeut, Shatin, Hong Kong, Peoples R China.;Chow, E (通讯作者)，Chinese Univ H
DIABETES RESEARCH AND CLINICAL PRACTICE, 2022; 193 ():
